Global Surrogacy Market-Industry Analysis and Forecast (2021-2027) – By Type, Technology, Age Group, Service Provider, and Region.

Global Surrogacy Market was valued US$ 19.8 Bn in 2020 and is expected to reach US$ 28.80 Bn by 2027, at a CAGR of 24.10 % during a forecast period. Global Surrogacy Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2016 to forecast the market through 2027. 2020 is considered a base year. Special attention is given to 2020 and effect of lockdown on the demand and supply, and also the impact of lockdown for next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

COVID-19 impact on market:

COVID-19 has the potential to have three major effects on the global economy: directly impacting production and demand, causing supply chain and market disruption, and having a financial impact on businesses and financial markets. Our analysts, who are monitoring the situation throughout the world, believe that the market would provide producers with lucrative opportunities following the COVID-19 dilemma.

Global Surrogacy Market definition

Surrogacy is a rapidly changing field. The advancement in assisted reproductive techniques such as donor insemination and embryo transfer methods have revolutionized the reproductive environment across the globe. Surrogacy arrangements are usually sought at the time when pregnancy is either medically impossible or it is considered risky for the health of the mother.

Global Surrogacy Market Dynamics:

An increase in awareness about infertility treatments available in the market has increased the adoption rate of surrogacy treatment. The rise in the number of people suffering from infertility problems coupled with advancements in reproductive technologies is expected to impact positively on the market growth. In addition, hormonal changes, age, excessive exposure to certain chemicals, and toxins are resulting in reduced sperm and egg production. Growth in the number of infertility cases are expected to boost market growth. An innovation in reproductive technologies has blessed infertile couples with their own babies with the surrogacy. On the other hand, strict regulations is expected to limit market growth.

Global Surrogacy Market Segment Analysis:

Surrogacy is available in two types, mainly gestational and traditional. Traditional surrogacy comprises the insemination of the surrogate naturally or artificially with the semen of the male partner of the childless couple. It has several ethical, social, and legal implications. On the other hand, in the case of gestational surrogacy, the artificial reproduction techniques (ART) and an embryo from the eggs of the intended couple are formed in the test tube and transferred to the womb of the surrogate. The technological advancement in Artificial Reproductive Techniques (ART) is expected to boom in the field of surrogacy. Surrogacy is becoming a popular way for many couples in the limelight to have children. Fertility clinics are adopting numerous strategies like digital marketing to build awareness about available treatment solutions for infertility problems to increase their customer case. Also, the rise in the number of infertility cases has triggered the number of fertility clinics and fertility specialists that are fueling the business growth. Many global surrogacy agencies are requiring women to live in dormitory-style housing throughout the duration of the pregnancy to enable access to nutritious foods, clean drinking water, and high-quality antenatal care. Global Surrogacy MarketIssues with Surrogacy: There are several ethical, social, psychological, and legal issues related with commercial surrogacy. In the United States and Argentina, surrogacy requirements are decided by independent surrogacy committees. In countries like the United Kingdom, Netherlands, Ireland, Denmark, Belgium, South Africa, Australia, Canada, and Greece only altruistic surrogacy is allowed. Furthermore, commercial surrogacy is legally allowed in countries like Russia, Ukraine, and Thailand. On the other hand, in France, Germany, Spain, Sweden, Italy, and Iceland any form of surrogacy is not allowed at all. Surrogacy in the United States is governed by state laws. Each individual state has created its own process for surrogacy, which is varying from no laws at all to more restrictive laws.

Global Surrogacy Market1Global Surrogacy Market Regional Analysis:

The International intended parents have many options available thanks to state-specific surrogacy laws. The United States has many locations where intended parents of all nationalities can safely pursue a surrogacy process. It protects their rights and also the rights of the surrogate that they work with. According to the Fertility clinics in the U.S. report, the assisted reproductive technology (ART) cycles started and carried out in their clinics. The ART includes all fertility treatments. According to the CDC’s 2018 Fertility Clinic report, the 306,197 ART cycles were performed at 456 reporting clinics in the United States in 2018. In that 306,197 ART cycles, 103,078 were egg or embryo banking cycles in which all eggs or embryos were frozen for future use. The objective of the report is to present a comprehensive analysis of the Global Surrogacy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Surrogacy Market dynamics, structure by analyzing the market segments and projects the global market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.

Global Surrogacy Market Scope: Inquire before buying

Global Surrogacy Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 19.8 Bn.
Forecast Period 2021 to 2027 CAGR: 24.10% Market Size in 2027: US $ 28.80 Bn.
Segments Covered: by Type • Gestational surrogacy • Traditional surrogacy
by Technology • Intrauterine insemination (IUI) • In-vitro fertilization (IVF) o Classical/standard IVF o Intracytoplasmic sperm injection (ICSI) • Others
by Age Group • Below 35 years • 35-37 years • 38 - 39 years • 40-42 years • 43-44 years • Over 44 years
by Service Provider • Hospitals • Fertility clinics • Others

Global Surrogacy Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Global Surrogacy Market Key players

New Hope Fertility CenterIVI-RMA GlobalScanfert AVA ClinicOvation Fertility • Bourn Hall Fertility Clinic • Morpheus Life Sciences Pvt. Ltd. • Growing Generations, LLC • Circle Surrogacy • Nova IVI Fertility • Bangkok IVF Center • Extraordinary Conceptions • Merck Serono • IARC Surrogacy • New Life Global Network • Max Healthcare • Care Fertility Group • Cardone & Associates Reproductive Medicine & Infertility, LLC Frequently Asked Questions: 1. Which region has the largest share in Global Surrogacy Market? Ans: North America region holds the highest share in 2020. 2. What is the growth rate of Global Surrogacy Market? Ans: The Global Surrogacy Market is growing at a CAGR of 24.1% during forecasting period 2021-2027. 3. What segments are covered in Global Surrogacy market? Ans: Global Surrogacy Market is segmented into type, technology, age group, service provider and region. 4. Who are the key players in Global Surrogacy market? Ans: The important key players in the Global Surrogacy Market are – New Hope Fertility Center, IVI-RMA Global, Scanfert AVA Clinic, Ovation Fertility, Bourn Hall Fertility Clinic, Morpheus Life Sciences Pvt. Ltd., Growing Generations, LLC, Circle Surrogacy, Nova IVI Fertility, Bangkok IVF Center, Extraordinary Conceptions, Merck Serono, IARC Surrogacy, New Life Global Network, Max Healthcare, Care Fertility Group 5. What is the study period of this market? Ans: The Global Surrogacy Market is studied from 2020 to 2027.
Global Surrogacy Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Surrogacy Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Surrogacy Market Analysis and Forecast 6.1. Surrogacy Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Surrogacy Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Surrogacy Market Value Share Analysis, By Type 7.4. Surrogacy Market Size (US$ Bn) Forecast, By Type 7.5. Surrogacy Market Analysis, By Type 7.6. Surrogacy Market Attractiveness Analysis, By Type 8. Global Surrogacy Market Analysis and Forecast, By Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Surrogacy Market Value Share Analysis, By Technology 8.4. Surrogacy Market Size (US$ Bn) Forecast, By Technology 8.5. Surrogacy Market Analysis, By Technology 8.6. Surrogacy Market Attractiveness Analysis, By Technology 9. Global Surrogacy Market Analysis and Forecast, By Age Group 9.1. Introduction and Definition 9.2. Key Findings 9.3. Surrogacy Market Value Share Analysis, By Age Group 9.4. Surrogacy Market Size (US$ Bn) Forecast, By Age Group 9.5. Surrogacy Market Analysis, By Age Group 9.6. Surrogacy Market Attractiveness Analysis, By Age Group 10. Global Surrogacy Market Analysis and Forecast, By Service Provider 10.1. Introduction and Definition 10.2. Key Findings 10.3. Surrogacy Market Value Share Analysis, By Service Provider 10.4. Surrogacy Market Size (US$ Bn) Forecast, By Service Provider 10.5. Surrogacy Market Analysis, By Service Provider 10.6. Surrogacy Market Attractiveness Analysis, By Service Provider 11. Global Surrogacy Market Analysis, by Region 11.1. Surrogacy Market Value Share Analysis, by Region 11.2. Surrogacy Market Size (US$ Bn) Forecast, by Region 11.3. Surrogacy Market Attractiveness Analysis, by Region 12. North America Surrogacy Market Analysis 12.1. Key Findings 12.2. North America Surrogacy Market Overview 12.3. North America Surrogacy Market Value Share Analysis, By Type 12.4. North America Surrogacy Market Forecast, By Type 12.4.1. Gestational surrogacy 12.4.2. Traditional surrogacy 12.5. North America Surrogacy Market Value Share Analysis, By Technology 12.6. North America Surrogacy Market Forecast, By Technology 12.6.1. Intrauterine insemination (IUI) 12.6.2. In-vitro fertilization (IVF) 12.6.2.1. Classical/standard IVF 12.6.2.2. Intracytoplasmic sperm injection (ICSI) 12.6.3. Others 12.7. North America Surrogacy Market Value Share Analysis, By Age Group 12.8. North America Surrogacy Market Forecast, By Age Group 12.8.1. Below 35 years 12.8.2. 35-37 years 12.8.3. 38 - 39 years 12.8.4. 40-42 years 12.8.5. 43-44 years 12.8.6. Over 44 years 12.9. North America Surrogacy Market Value Share Analysis, By Service Provider 12.10. North America Surrogacy Market Forecast, By Service Provider 12.10.1. Hospitals 12.10.2. Fertility clinics 12.10.3. Others 12.11. North America Surrogacy Market Value Share Analysis, by Country 12.12. North America Surrogacy Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Surrogacy Market Analysis, by Country 12.14. U.S. Surrogacy Market Forecast, By Type 12.14.1. Gestational surrogacy 12.14.2. Traditional surrogacy 12.15. U.S. Surrogacy Market Forecast, By Technology 12.15.1. Intrauterine insemination (IUI) 12.15.2. In-vitro fertilization (IVF) 12.15.2.1. Classical/standard IVF 12.15.2.2. Intracytoplasmic sperm injection (ICSI) 12.15.3. Others 12.16. U.S. Surrogacy Market Forecast, By Age Group 12.16.1. Below 35 years 12.16.2. 35-37 years 12.16.3. 38 - 39 years 12.16.4. 40-42 years 12.16.5. 43-44 years 12.16.6. Over 44 years 12.17. U.S. Surrogacy Market Forecast, By Service Provider 12.17.1. Hospitals 12.17.2. Fertility clinics 12.17.3. Others 12.18. Canada Surrogacy Market Forecast, By Type 12.18.1. Gestational surrogacy 12.18.2. Traditional surrogacy 12.19. Canada Surrogacy Market Forecast, By Technology 12.19.1. Intrauterine insemination (IUI) 12.19.2. In-vitro fertilization (IVF) 12.19.2.1. Classical/standard IVF 12.19.2.2. Intracytoplasmic sperm injection (ICSI) 12.19.3. Others 12.20. Canada Surrogacy Market Forecast, By Age Group 12.20.1. Below 35 years 12.20.2. 35-37 years 12.20.3. 38 - 39 years 12.20.4. 40-42 years 12.20.5. 43-44 years 12.20.6. Over 44 years 12.21. Canada Surrogacy Market Forecast, By Service Provider 12.21.1. Hospitals 12.21.2. Fertility clinics 12.21.3. Others 12.22. North America Surrogacy Market Attractiveness Analysis 12.22.1. By Type 12.22.2. By Technology 12.22.3. By Age Group 12.22.4. By Service Provider 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Surrogacy Market Analysis 13.1. Key Findings 13.2. Europe Surrogacy Market Overview 13.3. Europe Surrogacy Market Value Share Analysis, By Type 13.4. Europe Surrogacy Market Forecast, By Type 13.4.1. Gestational surrogacy 13.4.2. Traditional surrogacy 13.5. Europe Surrogacy Market Value Share Analysis, By Technology 13.6. Europe Surrogacy Market Forecast, By Technology 13.6.1. Intrauterine insemination (IUI) 13.6.2. In-vitro fertilization (IVF) 13.6.2.1. Classical/standard IVF 13.6.2.2. Intracytoplasmic sperm injection (ICSI) 13.6.3. Others 13.7. Europe Surrogacy Market Value Share Analysis, By Age Group 13.8. Europe Surrogacy Market Forecast, By Age Group 13.8.1. Below 35 years 13.8.2. 35-37 years 13.8.3. 38 - 39 years 13.8.4. 40-42 years 13.8.5. 43-44 years 13.8.6. Over 44 years 13.9. Europe Surrogacy Market Value Share Analysis, By Service Provider 13.10. Europe Surrogacy Market Forecast, By Service Provider 13.10.1. Hospitals 13.10.2. Fertility clinics 13.10.3. Others 13.11. Europe Surrogacy Market Value Share Analysis, by Country 13.12. Europe Surrogacy Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Surrogacy Market Analysis, by Country 13.14. Germany Surrogacy Market Forecast, By Type 13.14.1. Gestational surrogacy 13.14.2. Traditional surrogacy 13.15. Germany Surrogacy Market Forecast, By Technology 13.15.1. Intrauterine insemination (IUI) 13.15.2. In-vitro fertilization (IVF) 13.15.2.1. Classical/standard IVF 13.15.2.2. Intracytoplasmic sperm injection (ICSI) 13.15.3. Others 13.16. Germany Surrogacy Market Forecast, By Age Group 13.16.1. Below 35 years 13.16.2. 35-37 years 13.16.3. 38 - 39 years 13.16.4. 40-42 years 13.16.5. 43-44 years 13.16.6. Over 44 years 13.17. Germany Surrogacy Market Forecast, By Service Provider 13.17.1. Hospitals 13.17.2. Fertility clinics 13.17.3. Others 13.18. U.K. Surrogacy Market Forecast, By Type 13.18.1. Solutions 13.18.2. Services 13.18.2.1. Professional services 13.18.2.2. Managed services 13.19. U.K. Surrogacy Market Forecast, By Technology 13.19.1. Intrauterine insemination (IUI) 13.19.2. In-vitro fertilization (IVF) 13.19.2.1. Classical/standard IVF 13.19.2.2. Intracytoplasmic sperm injection (ICSI) 13.19.3. Others 13.20. U.K. Surrogacy Market Forecast, By Age Group 13.20.1. Below 35 years 13.20.2. 35-37 years 13.20.3. 38 - 39 years 13.20.4. 40-42 years 13.20.5. 43-44 years 13.20.6. Over 44 years 13.21. U.K. Surrogacy Market Forecast, By Service Provider 13.21.1. Hospitals 13.21.2. Fertility clinics 13.21.3. Others 13.22. France Surrogacy Market Forecast, By Type 13.22.1. Gestational surrogacy 13.22.2. Traditional surrogacy 13.23. France Surrogacy Market Forecast, By Technology 13.23.1. Intrauterine insemination (IUI) 13.23.2. In-vitro fertilization (IVF) 13.23.2.1. Classical/standard IVF 13.23.2.2. Intracytoplasmic sperm injection (ICSI) 13.23.3. Others 13.24. France Surrogacy Market Forecast, By Age Group 13.24.1. Below 35 years 13.24.2. 35-37 years 13.24.3. 38 - 39 years 13.24.4. 40-42 years 13.24.5. 43-44 years 13.24.6. Over 44 years 13.25. France Surrogacy Market Forecast, By Service Provider 13.25.1. Hospitals 13.25.2. Fertility clinics 13.25.3. Others 13.26. Italy Surrogacy Market Forecast, By Type 13.26.1. Gestational surrogacy 13.26.2. Traditional surrogacy 13.27. Italy Surrogacy Market Forecast, By Technology 13.27.1. Intrauterine insemination (IUI) 13.27.2. In-vitro fertilization (IVF) 13.27.2.1. Classical/standard IVF 13.27.2.2. Intracytoplasmic sperm injection (ICSI) 13.27.3. Others 13.28. Italy Surrogacy Market Forecast, By Age Group 13.28.1. Below 35 years 13.28.2. 35-37 years 13.28.3. 38 - 39 years 13.28.4. 40-42 years 13.28.5. 43-44 years 13.28.6. Over 44 years 13.29. Italy Surrogacy Market Forecast, By Service Provider 13.29.1. Hospitals 13.29.2. Fertility clinics 13.29.3. Others 13.30. Spain Surrogacy Market Forecast, By Type 13.30.1. Gestational surrogacy 13.30.2. Traditional surrogacy 13.31. Spain Surrogacy Market Forecast, By Technology 13.31.1. Intrauterine insemination (IUI) 13.31.2. In-vitro fertilization (IVF) 13.31.2.1. Classical/standard IVF 13.31.2.2. Intracytoplasmic sperm injection (ICSI) 13.31.3. Others 13.32. Spain Surrogacy Market Forecast, By Age Group 13.32.1. Below 35 years 13.32.2. 35-37 years 13.32.3. 38 - 39 years 13.32.4. 40-42 years 13.32.5. 43-44 years 13.32.6. Over 44 years 13.33. Spain Surrogacy Market Forecast, By Service Provider 13.33.1. Hospitals 13.33.2. Fertility clinics 13.33.3. Others 13.34. Rest of Europe Surrogacy Market Forecast, By Type 13.34.1. Gestational surrogacy 13.34.2. Traditional surrogacy 13.35. Rest of Europe Surrogacy Market Forecast, By Technology 13.35.1. Intrauterine insemination (IUI) 13.35.2. In-vitro fertilization (IVF) 13.35.2.1. Classical/standard IVF 13.35.2.2. Intracytoplasmic sperm injection (ICSI) 13.35.3. Others 13.36. Rest of Europe Surrogacy Market Forecast, By Age Group 13.36.1. Below 35 years 13.36.2. 35-37 years 13.36.3. 38 - 39 years 13.36.4. 40-42 years 13.36.5. 43-44 years 13.36.6. Over 44 years 13.37. Rest Of Europe Surrogacy Market Forecast, By Service Provider 13.37.1. Hospitals 13.37.2. Fertility clinics 13.37.3. Others 13.38. Europe Surrogacy Market Attractiveness Analysis 13.38.1. By Type 13.38.2. By Technology 13.38.3. By Age Group 13.38.4. By Service Provider 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Surrogacy Market Analysis 14.1. Key Findings 14.2. Asia Pacific Surrogacy Market Overview 14.3. Asia Pacific Surrogacy Market Value Share Analysis, By Type 14.4. Asia Pacific Surrogacy Market Forecast, By Type 14.4.1. Gestational surrogacy 14.4.2. Traditional surrogacy 14.5. Asia Pacific Surrogacy Market Value Share Analysis, By Technology 14.6. Asia Pacific Surrogacy Market Forecast, By Technology 14.6.1. Intrauterine insemination (IUI) 14.6.2. In-vitro fertilization (IVF) 14.6.2.1. Classical/standard IVF 14.6.2.2. Intracytoplasmic sperm injection (ICSI) 14.6.3. Others 14.7. Asia Pacific Surrogacy Market Value Share Analysis, By Age Group 14.8. Asia Pacific Surrogacy Market Forecast, By Age Group 14.8.1. Below 35 years 14.8.2. 35-37 years 14.8.3. 38 - 39 years 14.8.4. 40-42 years 14.8.5. 43-44 years 14.8.6. Over 44 years 14.9. Asia Pacific Surrogacy Market Value Share Analysis, By Service Provider 14.10. Asia Pacific Surrogacy Market Forecast, By Service Provider 14.10.1. Hospitals 14.10.2. Fertility clinics 14.10.3. Others 14.11. Asia Pacific Surrogacy Market Value Share Analysis, by Country 14.12. Asia Pacific Surrogacy Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Surrogacy Market Analysis, by Country 14.14. China Surrogacy Market Forecast, By Type 14.14.1. Gestational surrogacy 14.14.2. Traditional surrogacy 14.15. China Surrogacy Market Forecast, By Technology 14.15.1. Intrauterine insemination (IUI) 14.15.2. In-vitro fertilization (IVF) 14.15.2.1. Classical/standard IVF 14.15.2.2. Intracytoplasmic sperm injection (ICSI) 14.15.3. Others 14.16. China Surrogacy Market Forecast, By Age Group 14.16.1. Below 35 years 14.16.2. 35-37 years 14.16.3. 38 - 39 years 14.16.4. 40-42 years 14.16.5. 43-44 years 14.16.6. Over 44 years 14.17. China Surrogacy Market Forecast, By Service Provider 14.17.1. Hospitals 14.17.2. Fertility clinics 14.17.3. Others 14.18. India Surrogacy Market Forecast, By Type 14.18.1. Gestational surrogacy 14.18.2. Traditional surrogacy 14.19. India Surrogacy Market Forecast, By Technology 14.19.1. Intrauterine insemination (IUI) 14.19.2. In-vitro fertilization (IVF) 14.19.2.1. Classical/standard IVF 14.19.2.2. Intracytoplasmic sperm injection (ICSI) 14.19.3. Others 14.20. India Surrogacy Market Forecast, By Age Group 14.20.1. Below 35 years 14.20.2. 35-37 years 14.20.3. 38 - 39 years 14.20.4. 40-42 years 14.20.5. 43-44 years 14.20.6. Over 44 years 14.21. India Surrogacy Market Forecast, By Service Provider 14.21.1. Hospitals 14.21.2. Fertility clinics 14.21.3. Others 14.22. Japan Surrogacy Market Forecast, By Type 14.22.1. Gestational surrogacy 14.22.2. Traditional surrogacy 14.23. Japan Surrogacy Market Forecast, By Technology 14.23.1. Intrauterine insemination (IUI) 14.23.2. In-vitro fertilization (IVF) 14.23.2.1. Classical/standard IVF 14.23.2.2. Intracytoplasmic sperm injection (ICSI) 14.23.3. Others 14.24. Japan Surrogacy Market Forecast, By Age Group 14.24.1. Below 35 years 14.24.2. 35-37 years 14.24.3. 38 - 39 years 14.24.4. 40-42 years 14.24.5. 43-44 years 14.24.6. Over 44 years 14.25. Japan Surrogacy Market Forecast, By Service Provider 14.25.1. Hospitals 14.25.2. Fertility clinics 14.25.3. Others 14.26. ASEAN Surrogacy Market Forecast, By Type 14.26.1. Gestational surrogacy 14.26.2. Traditional surrogacy 14.27. ASEAN Surrogacy Market Forecast, By Technology 14.27.1. Intrauterine insemination (IUI) 14.27.2. In-vitro fertilization (IVF) 14.27.2.1. Classical/standard IVF 14.27.2.2. Intracytoplasmic sperm injection (ICSI) 14.27.3. Others 14.28. ASEAN Surrogacy Market Forecast, By Age Group 14.28.1. Below 35 years 14.28.2. 35-37 years 14.28.3. 38 - 39 years 14.28.4. 40-42 years 14.28.5. 43-44 years 14.28.6. Over 44 years 14.29. ASEAN Surrogacy Market Forecast, By Service Provider 14.29.1. Hospitals 14.29.2. Fertility clinics 14.29.3. Others 14.30. Rest of Asia Pacific Surrogacy Market Forecast, By Type 14.30.1. Gestational surrogacy 14.30.2. Traditional surrogacy 14.31. Rest of Asia Pacific Surrogacy Market Forecast, By Technology 14.31.1. Intrauterine insemination (IUI) 14.31.2. In-vitro fertilization (IVF) 14.31.2.1. Classical/standard IVF 14.31.2.2. Intracytoplasmic sperm injection (ICSI) 14.31.3. Others 14.32. Rest of Asia Pacific Surrogacy Market Forecast, By Age Group 14.32.1. Below 35 years 14.32.2. 35-37 years 14.32.3. 38 - 39 years 14.32.4. 40-42 years 14.32.5. 43-44 years 14.32.6. Over 44 years 14.33. Rest of Asia Pacific Surrogacy Market Forecast, By Service Provider 14.33.1. Hospitals 14.33.2. Fertility clinics 14.33.3. Others 14.34. Asia Pacific Surrogacy Market Attractiveness Analysis 14.34.1. By Type 14.34.2. By Technology 14.34.3. By Age Group 14.34.4. By Service Provider 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Surrogacy Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Surrogacy Market Overview 15.3. Middle East & Africa Surrogacy Market Value Share Analysis, By Type 15.4. Middle East & Africa Surrogacy Market Forecast, By Type 15.4.1. Gestational surrogacy 15.4.2. Traditional surrogacy 15.5. Middle East & Africa Surrogacy Market Value Share Analysis, By Technology 15.6. Middle East & Africa Surrogacy Market Forecast, By Technology 15.6.1. Intrauterine insemination (IUI) 15.6.2. In-vitro fertilization (IVF) 15.6.2.1. Classical/standard IVF 15.6.2.2. Intracytoplasmic sperm injection (ICSI) 15.6.3. Others 15.7. Middle East & Africa Surrogacy Market Value Share Analysis, By Age Group 15.8. Middle East & Africa Surrogacy Market Forecast, By Age Group 15.8.1. Below 35 years 15.8.2. 35-37 years 15.8.3. 38 - 39 years 15.8.4. 40-42 years 15.8.5. 43-44 years 15.8.6. Over 44 years 15.9. Middle East & Africa Surrogacy Market Value Share Analysis, By Service Provider 15.10. Middle East & Africa Surrogacy Market Forecast, By Service Provider 15.10.1. Hospitals 15.10.2. Fertility clinics 15.10.3. Others 15.11. Middle East & Africa Surrogacy Market Value Share Analysis, by Country 15.12. Middle East & Africa Surrogacy Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Surrogacy Market Analysis, by Country 15.14. GCC Surrogacy Market Forecast, By Type 15.14.1. Gestational surrogacy 15.14.2. Traditional surrogacy 15.15. GCC Surrogacy Market Forecast, By Technology 15.15.1. Intrauterine insemination (IUI) 15.15.2. In-vitro fertilization (IVF) 15.15.2.1. Classical/standard IVF 15.15.2.2. Intracytoplasmic sperm injection (ICSI) 15.15.3. Others 15.16. GCC Surrogacy Market Forecast, By Age Group 15.16.1. Below 35 years 15.16.2. 35-37 years 15.16.3. 38 - 39 years 15.16.4. 40-42 years 15.16.5. 43-44 years 15.16.6. Over 44 years 15.17. GCC Surrogacy Market Forecast, By Service Provider 15.17.1. Hospitals 15.17.2. Fertility clinics 15.17.3. Others 15.18. South Africa Surrogacy Market Forecast, By Type 15.18.1. Gestational surrogacy 15.18.2. Traditional surrogacy 15.19. South Africa Surrogacy Market Forecast, By Technology 15.19.1. Intrauterine insemination (IUI) 15.19.2. In-vitro fertilization (IVF) 15.19.2.1. Classical/standard IVF 15.19.2.2. Intracytoplasmic sperm injection (ICSI) 15.19.3. Others 15.20. South Africa Surrogacy Market Forecast, By Age Group 15.20.1. Below 35 years 15.20.2. 35-37 years 15.20.3. 38 - 39 years 15.20.4. 40-42 years 15.20.5. 43-44 years 15.20.6. Over 44 years 15.21. South Africa Surrogacy Market Forecast, By Service Provider 15.21.1. Hospitals 15.21.2. Fertility clinics 15.21.3. Others 15.22. Rest of Middle East & Africa Surrogacy Market Forecast, By Type 15.22.1. Gestational surrogacy 15.22.2. Traditional surrogacy 15.23. Rest of Middle East & Africa Surrogacy Market Forecast, By Technology 15.23.1. Intrauterine insemination (IUI) 15.23.2. In-vitro fertilization (IVF) 15.23.2.1. Classical/standard IVF 15.23.2.2. Intracytoplasmic sperm injection (ICSI) 15.23.3. Others 15.24. Rest of Middle East & Africa Surrogacy Market Forecast, By Age Group 15.24.1. Below 35 years 15.24.2. 35-37 years 15.24.3. 38 - 39 years 15.24.4. 40-42 years 15.24.5. 43-44 years 15.24.6. Over 44 years 15.25. Rest of Middle East & Africa Surrogacy Market Forecast, By Service Provider 15.25.1. Hospitals 15.25.2. Fertility clinics 15.25.3. Others 15.26. Middle East & Africa Surrogacy Market Attractiveness Analysis 15.26.1. By Type 15.26.2. By Technology 15.26.3. By Age Group 15.26.4. By Service Provider 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Surrogacy Market Analysis 16.1. Key Findings 16.2. South America Surrogacy Market Overview 16.3. South America Surrogacy Market Value Share Analysis, By Type 16.4. South America Surrogacy Market Forecast, By Type 16.4.1. Gestational surrogacy 16.4.2. Traditional surrogacy 16.5. South America Surrogacy Market Value Share Analysis, By Technology 16.6. South America Surrogacy Market Forecast, By Technology 16.6.1. Intrauterine insemination (IUI) 16.6.2. In-vitro fertilization (IVF) 16.6.2.1. Classical/standard IVF 16.6.2.2. Intracytoplasmic sperm injection (ICSI) 16.6.3. Others 16.7. South America Surrogacy Market Value Share Analysis, By Age Group 16.8. South America Surrogacy Market Forecast, By Age Group 16.8.1. Below 35 years 16.8.2. 35-37 years 16.8.3. 38 - 39 years 16.8.4. 40-42 years 16.8.5. 43-44 years 16.8.6. Over 44 years 16.9. South America Surrogacy Market Value Share Analysis, By Service Provider 16.10. South America Surrogacy Market Forecast, By Service Provider 16.10.1. Hospitals 16.10.2. Fertility clinics 16.10.3. Others 16.11. South America Surrogacy Market Value Share Analysis, by Country 16.12. South America Surrogacy Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Surrogacy Market Analysis, by Country 16.14. Brazil Surrogacy Market Forecast, By Type 16.14.1. Gestational surrogacy 16.14.2. Traditional surrogacy 16.15. Brazil Surrogacy Market Forecast, By Technology 16.15.1. Intrauterine insemination (IUI) 16.15.2. In-vitro fertilization (IVF) 16.15.2.1. Classical/standard IVF 16.15.2.2. Intracytoplasmic sperm injection (ICSI) 16.15.3. Others 16.16. Brazil Surrogacy Market Forecast, By Age Group 16.16.1. Below 35 years 16.16.2. 35-37 years 16.16.3. 38 - 39 years 16.16.4. 40-42 years 16.16.5. 43-44 years 16.16.6. Over 44 years 16.17. Brazil Surrogacy Market Forecast, By Service Provider 16.17.1. Hospitals 16.17.2. Fertility clinics 16.17.3. Others 16.18. Mexico Surrogacy Market Forecast, By Type 16.18.1. Gestational surrogacy 16.18.2. Traditional surrogacy 16.19. Mexico Surrogacy Market Forecast, By Technology 16.19.1. Intrauterine insemination (IUI) 16.19.2. In-vitro fertilization (IVF) 16.19.2.1. Classical/standard IVF 16.19.2.2. Intracytoplasmic sperm injection (ICSI) 16.19.3. Others 16.20. Mexico Surrogacy Market Forecast, By Age Group 16.20.1. Below 35 years 16.20.2. 35-37 years 16.20.3. 38 - 39 years 16.20.4. 40-42 years 16.20.5. 43-44 years 16.20.6. Over 44 years 16.21. Mexico Surrogacy Market Forecast, By Service Provider 16.21.1. Hospitals 16.21.2. Fertility clinics 16.21.3. Others 16.22. Rest of South America Surrogacy Market Forecast, By Type 16.22.1. Gestational surrogacy 16.22.2. Traditional surrogacy 16.23. Rest of South America Surrogacy Market Forecast, By Technology 16.23.1. Intrauterine insemination (IUI) 16.23.2. In-vitro fertilization (IVF) 16.23.2.1. Classical/standard IVF 16.23.2.2. Intracytoplasmic sperm injection (ICSI) 16.23.3. Others 16.24. Rest of South America Surrogacy Market Forecast, By Age Group 16.24.1. Below 35 years 16.24.2. 35-37 years 16.24.3. 38 - 39 years 16.24.4. 40-42 years 16.24.5. 43-44 years 16.24.6. Over 44 years 16.25. Rest of South America Surrogacy Market Forecast, By Service Provider 16.25.1. Hospitals 16.25.2. Fertility clinics 16.25.3. Others 16.26. South America Surrogacy Market Attractiveness Analysis 16.26.1. By Type 16.26.2. By Technology 16.26.3. By Age Group 16.26.4. By Service Provider 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Age Groups, and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.4. M&A by Regions, Investment and Age Groups 17.2.5. M&A Key Players, Forward Support & Maintenance and Backward Support & Maintenance 17.3. Company Profiles: Key Players 17.3.1. New Hope Fertility Center 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. IVI-RMA Global 17.3.3. Scanfert AVA Clinic 17.3.4. Ovation Fertility 17.3.5. Bourn Hall Fertility Clinic 17.3.6. Morpheus Life Sciences Pvt. Ltd. 17.3.7. Growing Generations, LLC 17.3.8. Circle Surrogacy 17.3.9. Nova IVI Fertility 17.3.10. Bangkok IVF Center 17.3.11. Extraordinary Conceptions 17.3.12. Merck Serono 17.3.13. IARC Surrogacy 17.3.14. New Life Global Network 17.3.15. Max Healthcare 17.3.16. Cardone & Associates Reproductive Medicine & Infertility, LLC

About This Report

Report ID 66844
Category Healthcare
Published Date July 2020
Updated Date Sept 2021
Contact Us